Global Mammography Machine Market - 2025-2033

The global mammography machine market reached US$ 2.6 billion in 2024 and is expected to reach US$ 4.1 billion by 2033, growing at a CAGR of 5.1% during the forecast period 2025-2033.

A mammography machine is a specialized medical imaging device used for early detection and diagnosis of breast cancer by capturing detailed X-ray images (called mammograms) of the breast tissue. The primary purpose of the mammography machine is to detect abnormalities such as lumps, tumors, calcifications, or other signs that could indicate breast cancer or other medical conditions, often before any symptoms are noticeable.

Screening mammography is performed on asymptomatic women to detect early signs of breast cancer, diagnostic mammography is performed when there are signs or symptoms such as lumps, pain, or abnormal findings from a previous screening, follow-up mammography is used to monitor previously identified conditions or after treatments like surgery or radiation.

The demand for mammography machines has been increasing due to several factors, including the rise in breast cancer cases, advancements in technology and government health initiatives. The rising adoption of mammography machines for breast cancer screening, diagnosis and follow-ups is also a significant factor driving the market demand. For instance, in June 2024, FUJIFIM India Healthcare in collaboration with NM Medical Mumbai, launched its first Fujifilm Skill Lab for providing advanced training in FFDM (full-field digital mammography) technologies for radiologists and radiographers.

Market Dynamics: Drivers & Restraints

Rising prevalence of breast cancer

The rising prevalence of breast cancer is significantly driving the growth of the mammography machine market and is expected to drive the market over the forecast period. According to the World Health Organization (WHO), in 2022, 2.3 million women were diagnosed with breast cancer. Breast cancer affects women of all ages after puberty, although the incidence rises later in life. Additionally, according to the Breast Cancer Organization, in 2024, approximately 310,720 women diagnosed with invasive breast cancer, 16% of which will be in women younger than 50 years of age in the United States. This growing incidence creates a larger pool of patients who require early screening for diagnosis and treatment.

Early diagnosis of breast cancer greatly improves treatment outcomes and survival rates. Mammography is the gold standard for breast cancer screening, especially for women over the age of 40. This increasing focus on early detection drives greater adoption of mammography machines. The risk of breast cancer increases with age. According to the American Cancer Society, about 80% of breast cancer cases are diagnosed in women over the age of 50. As the global population ages, particularly in countries with longer life expectancies, the demand for mammography machines for regular screenings continues to grow.

Initiatives like Breast Cancer Awareness Month and the Pink Ribbon Campaign have significantly increased public awareness of the importance of early breast cancer detection. This has contributed to rising demand for mammography machines, particularly in emerging markets such as India, China, and Brazil, where breast cancer rates are rising due to lifestyle changes and aging populations.

High cost of mammography machines

The high cost of mammography machines is a significant barrier to the growth of the mammography machine market, especially in low-resource settings and developing countries. The cost of a mammography machine can vary however the average price range for an entry-level machine is $55,000 to $75,000. The cost of modern digital mammography and 3D mammography (Tomosynthesis) systems can be quite high. A digital mammography machine can range from USD 150,000 to USD 300,000 per unit, depending on the features (e.g., AI integration and advanced imaging capabilities).

The high maintenance costs of mammography machines add to the total financial burden. These machines require regular calibration, service contracts and software updates, which can lead to additional expenses. Consumables such as film (for older analog systems) or disposable imaging components and spare parts for maintenance contribute to ongoing costs. The need for trained professionals to operate and maintain these systems also increases operational costs.

Segment Analysis

The global mammography machine market is segmented based on product type, technology, dimension, application, end-user and region.

Product Type:

The digital mammography machine segment is expected to dominate the mammography machine market share

Digital mammography machines provide faster breast screening which further helps to promote early diagnosis of breast cancer. The ability to instantly view and store images digitally speeds up the process, improving workflow efficiency and reducing wait times for patients. With digital systems, images are available within minutes, which allows for quick diagnosis and reduced patient anxiety. Digital mammography reduces the need for physical films and manual development processes, making it more cost-effective in the long term.

For instance, in June 2024, Healthway Medical Network (HMN) launched a new digital mammography machine at its multi-specialty center. This new device offers high-resolution imaging for breast cancer screening, enabling the center's doctors to identify potential abnormalities with better accuracy. Moreover, its adoption is aligned with HMN's initiative of offering comprehensive screenings to promote early diagnosis among patients.

Digital mammography provides better image clarity and higher diagnostic accuracy compared to traditional film-based mammography, particularly for women with dense breast tissue. The ability to digitally manipulate images (contrast, zoom, etc.) also aids in detecting early-stage cancers that might be missed in film mammography.

Geographical Analysis

North America is expected to hold a significant position in the mammography machine market share

Breast cancer is the most common cancer among women in North America especially in the United States and Canada, with a significantly higher incidence compared to many other regions. For instance, according to the American Cancer Society, breast cancer is the second most frequent cancer in women in the United States, and it is the top cause of cancer mortality among Hispanic women. In 2024, 310,720 women were diagnosed with invasive breast cancer, with a projected 42,250 deaths. This high prevalence drives the demand for breast cancer screening and diagnostic tools like mammography machines.

Additionally, according to the Canadian Cancer Society, in 2022, an estimated 28,600 Canadian women were diagnosed with breast cancer. With increasing breast cancer cases, awareness about breast cancer and its early detection is also rising, there is a strong demand for mammography screenings in North America, particularly for women aged 40 and above. Mammography remains the gold standard for early breast cancer detection in the region.

North America has been a leader in the adoption of advanced mammography technologies, such as digital mammography and 3D mammography (tomosynthesis). The adoption of Full-Field Digital Mammography (FFDM) and 3D systems has been particularly strong, thanks to their higher diagnostic accuracy and better detection rates compared to traditional film-based systems.

For instance, in January 2025, GRACE Breast Imaging & Medical Spa of Iowa recently became the first healthcare facility in the United States to install the new Mammomat B.brilliant. The Mammomat B.brilliant is Siemens Healthineers' first completely redesigned mammography machine in over a decade. It includes new 3D image acquisition and reconstruction technology, as well as features for full-field digital mammography or two-dimensional breast imaging, breast biopsy, and titanium contrast-enhanced mammography.

Asia-Pacific is growing at the fastest pace in the mammography machine market

Awareness campaigns focused on early detection and screening are significantly raising the demand for mammography machines in the region. As breast cancer awareness rises, more women are seeking regular screening, driving the need for modern mammography equipment. In countries like India and China, breast cancer awareness is gradually increasing due to efforts by non-profit organizations, media, and healthcare professionals. These campaigns are encouraging women to get screened regularly, which directly drives demand for mammography machines.

For instance, Breast Cancer Awareness Month, commemorated every October, has a unique importance worldwide, but notably in India. In a nation where breast cancer is growing more common, this awareness month acts as an important effort to educate, empower, and motivate action. This has led to greater utilization of mammography services in metropolitan and rural regions.

Competitive Landscape

The major global players in the mammography machine market include GE HealthCare, Siemens Healthineers AG, Hologic, Inc., FUJIFILM Holdings Corporation, PLANMED OY, Koninklijke Philips N.V., Metaltronica S.p.A., Konica Minolta Healthcare Americas, Inc., Carestream Health, CANON MEDICAL SYSTEMS ARGENTINA S.A. and among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global mammography machine market report delivers a detailed analysis with 78 key tables, more than 70 visually impactful figures, and 168 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.